PositoAI/ US/ Replimune Group, Inc.

Replimune Group, Inc.

NasdaqGS: REPL · Healthcare

Positivity Index

#5,918 / 6,774

Global

#3,315 / 4,000

United States

Positivity Score

13,984

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Replimune Group, Inc. — Overview & Financial Snapshot

Replimune Group, Inc. (NasdaqGS: REPL) is a Healthcare company, ranked #5,918 of 6,774 companies globally and #3,315 of 4,000 in United States on PositoAI, with a Positivity Score of 13,984. Its market capitalisation is ₹10,663.27 Cr ($1.13B), P/E ratio is -3.8 and P/B ratio is 10.69. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that expresses an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4. The company was founded in 2015 and is headquartered in Woburn, Massachusetts.

P/B Ratio 10.69

P/E Ratio -3.8

D/E Ratio 1.06

ROE -134.29%

Owes vs Owns ? 0.58× Moderate $0.58 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-297.33$-3.15

Forward EPS ₹-171.67$-1.82

Beta 0.94

Market Cap ₹10,663.27 Cr$1.13B

What these numbers mean →

What does Replimune Group, Inc. do?

What is Replimune Group, Inc.'s P/E and P/B ratio?

Replimune Group, Inc. has a P/E ratio of -3.8 and a P/B ratio of 10.69.

What is Replimune Group, Inc.'s debt-to-equity ratio?

Replimune Group, Inc. has a debt-to-equity ratio of 1.06.

How much does Replimune Group, Inc. owe compared with what it owns?

Replimune Group, Inc. owes $0.58 for every $1 it owns (balance sheet Jun 2026), which is moderate.

What is Replimune Group, Inc.'s Positivity rank?

Replimune Group, Inc. is ranked #5,918 of 6,774 companies globally and #3,315 of 4,000 in United States on PositoAI, with a Positivity Score of 13,984.

Does Replimune Group, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Replimune Group, Inc..

Where can I read the latest news about Replimune Group, Inc.?

Recent headlines about Replimune Group, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Replimune Group, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Replimune Group, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.